| |
Chairman, Chief Executive Officer & Managing Director Guo Xia William
Executive Director Song Xue Mei Maria
Non-executive Directors Zhang Li, Wang Dajun Denis
Independent Non-executive Directors Ni Bin Hui, Wu Shuangsi, Guo Tong,
Liu Na
|
- The Group is principally engaged in the research, development and commercialization of
drug products.
|
| Major Shareholders |
|
 |
| Shareholders |
Current Holding |
% Held |
Date |
Previous Holding |
% Held |
Date |
| DIRECTOR GUO XIA WILLIAM&ASSO |
705,418,578 |
70.870 |
2023/09/30 |
705,418,578 |
70.870 |
2023/06/30 |
|
|
Copyright ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms
of use.
DISCLAIMER: ET Net Limited
and Hong Kong Exchanges and Clearing Limited endeavour to ensure the accuracy
and reliability of the information provided, but do not guarantee its
accuracy and reliability and accept no liability (whether in tort or contract
or otherwise) for any loss or damage arising from any inaccuracies or
omissions.
|
|
